SciELO - Scientific Electronic Library Online

 
vol.29 número3Evaluación del riesgo biológico en la producción de vacunas inactivadas de uso animalAplicación del análisis de componentes principales en la formación de dímeros durante la purificación de un anticuerpo monoclonal índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Vaccimonitor

versión impresa ISSN 1025-028Xversión On-line ISSN 1025-0298

Resumen

RODRIGUEZ-SANTOS, Olimpio et al. Immunotherapy with mite allergens in patients with allergic rhinitis and obstructive sleep apnea. Vaccimonitor [online]. 2020, vol.29, n.3, pp.103-108.  Epub 01-Dic-2020. ISSN 1025-028X.

To confirm the presence of obstructive sleep apnea (OSA) in allergic rhinitis (AR), cardiorespiratory polygraphy (CRP) was performed, and to treat both conditions, the allergen specific immunotherapy (ASIT) was used in order to change their course. Descriptive study in the universe of patients from “Previsora” polyclinic Allergology service, Camagüey, Cuba was carried-out from December 2018 to March 2020. 326 patients were selected in consecutive order of attendance at the consultation, taking into account the criteria: ≥5 years with AR, suspicion of OSA and positive skin test to: Dermatophagoides pteronyssinus, Dermatophagoides siboney and Blomia tropicalis, supplied by the "National Center for Biopreparations" in Cuba. All patients received ASIT for ≥10 months and CRP was performed before and after ASIT. The CRP results were taken from the automatic scoring of the ApneaLink AirTM device (Resmed Corp., Australia), validated to study OSA at home. The skin test and CRP results were evaluated before and after the ASIT. In addition, the assessment of the ASIT efficacy according to criteria of patients and professionals was performed. The sample was made-up of 152 female patients (46.6%) and 174 males (53.4%); those with 5 to 6 mm wheal were the most represented (p=0.04). There was decrease in OSA severity levels after ASIT (p=0.025). The ASIT efficacy was proved with a significant number of improvements (p=0.012). CRP provides the diagnosis of OSA in AR, and ASIT changes the course of both conditions.

Palabras clave : Obstructive sleep apnea; allergic rhinitis; skin tests; mites; immunotherapy.

        · resumen en Español     · texto en Español     · Español ( pdf )